PF-07304814
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-07304814, covering 2023-05-03 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants [Phase 1]